文献速递瓣膜外科

心房功能性二尖瓣反流与退行性病因二尖瓣手术结局对比

Surgical outcome of mitral valve surgery in atrial functional mitral regurgitation compared with degenerative etiology.
PubMed 文献 · J Thorac Cardiovasc Surg · 2024-06-13

本研究比较心房功能性二尖瓣反流(AFMR)与退行性二尖瓣反流(DMR)患者二尖瓣手术结局,纳入2012年1月至2022年12月两家机构642例患者,倾向性评分匹配后DMR组164例、AFMR组82例。AFMR组5年心力衰竭再入院或心源性死亡免除率较低(88.6% vs 96.3%,P=0.045),心源性死亡免除率亦较低(90.0% vs 100%,P=0.002);二尖瓣反流复发率无显著差异。AFMR组迷宫术后交界性心律及永久起搏器植入比例更高。

要点

  • AFMR组5年心衰再入院或心源性死亡免除率88.6%,低于DMR组96.3%(P=0.045)。
  • AFMR组5年心源性死亡免除率90.0%,低于DMR组100%(P=0.002)。
  • AFMR组迷宫术后交界性心律49.1%,高于DMR组3.3%(P<0.001);5年后永久起搏器植入11.4% vs 1.5%(P=0.041)。

核心结论

  • AFMR患者二尖瓣手术结局可接受,二尖瓣修复是良好的治疗选择;但迷宫术后交界性心律显著更多,需更多永久起搏器植入。

研究设计与样本

  • 回顾性比较研究,纳入2012年1月至2022年12月两家机构因AFMR或DMR行二尖瓣修复/置换的患者,排除<18岁及合并其他心脏手术(迷宫术或三尖瓣环成形除外)者,采用倾向性评分分析校正基线差异。
  • 共纳入642例患者,倾向性评分分析后DMR组164例、AFMR组82例;匹配后两组患者均有心房颤动。

主要发现

  • 5年心力衰竭再入院或心源性死亡免除率:DMR组96.3% vs AFMR组88.6%(P=0.045)。
  • 5年心源性死亡免除率:DMR组100% vs AFMR组90.0%(P=0.002)。
  • 二尖瓣修复后显著二尖瓣反流复发率两组无显著差异(P=0.699,log-rank检验),5年二尖瓣反流复发(中度及以上)免除率DMR组89.8% vs AFMR组93.0%。
  • 迷宫术后交界性心律:AFMR组49.1% vs DMR组3.3%(P<0.001)。
  • 随访期永久起搏器植入(5年后):AFMR组11.4% vs DMR组1.5%(P=0.041,log-rank检验)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To analyze and compare the outcomes of mitral valve surgery for atrial functional mitral regurgitation (AFMR) and for degenerative mitral regurgitation (DMR). METHODS: Patients with AFMR or DMR who underwent mitral valve repair/replacement at 2 institutions between January 2012 and December 2022 were included. Patients <18 years of age and patients undergoing concomitant cardiac surgery (except for the maze procedure or tricuspid annuloplasty) were excluded. Propensity score analysis was used to adjust for baseline differences. RESULTS: A total of 642 patients were enrolled. After propensity score analysis, 164 patients were classified into the DMR group, and 82 patients were classified into the AFMR group. All matched patients in both groups had atrial fibrillation. In DMR and AFMR, the 5-year freedom from readmission for heart failure and cardiac death was 96.3% in the DMR group versus 88.6% in the AFMR group (P = .045) and freedom from readmission for cardiac death in the 2 groups was 100% and 90.0%, respectively (P = .002). The recurrence rate of significant mitral regurgitation (MR) after mitral valve repair was not significantly different between the 2 groups (P = .699, log-rank test), and the 5-year freedom from MR recurrence (moderate or greater) was 89.8% and 93.0%, respectively. After the maze procedure, significantly more patients in the AFMR group than the DMR group were in junctional rhythm (49.1% vs 3.3%; P < .001) and required permanent pacemaker insertion during the follow-up period (11.4% vs 1.5% after 5 years; P = .041, log-rank test). CONCLUSIONS: AFMR was associated with acceptable outcomes of mitral valve surgery, and mitral valve repair is a good treatment option. However, significantly more patients were in junctional rhythm after the maze procedure, needing more permanent pacemaker insertion.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Song K, Lee JH, Woo HT, et al. Surgical outcome of mitral valve surgery in atrial functional mitral regurgitation compared with degenerative etiology. J Thorac Cardiovasc Surg. 2024. PMID: 38879118. doi:10.1016/j.jtcvs.2024.06.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。